A Randomized Trial to Assess Safety and Immunogenicity of Alternative Formulations of a Quadrivalent Meningococcal (A, C, Y, and W-135) Tetanus Protein Conjugate Vaccine in Toddlers
Jodie McVernon, Terry Nolan, Peter Richmond, Graham Reynolds, Michael Nissen, Stephen B Lambert, Helen Marshall, Thomas Papa, Christine Rehm
Pediatric Infectious Disease Journal | LIPPINCOTT WILLIAMS & WILKINS | Published : 2012
Related Projects (1)
Awarded by National Health and Medical Research Council
J.M. (566635) and H.M. (1016272) supported by National Health and Medical Research Council Career Development Fellowships. The study was supported by Sanofi Pasteur. T.P. and C.R. are employees of Sanofi Pasteur. All other authors have acted as investigators on studies funded by Sanofi Pasteur and other vaccine manufacturers, through contractual arrangements with their respective institutions. J.M., T.N., P.R., G.R., M.N., S.L., and H.M. have received financial support from manufacturers to attend meetings and conferences to present scientific data. The authors have no other funding or conflicts of interest to disclose.